$1.15 EPS Expected for Novartis AG (ADR) (NVS); Fifth Third Bancorp (FITB) Sellers Decreased By 2.67% Their Shorts

Fifth Third Bancorp (NASDAQ:FITB) had a decrease of 2.67% in short interest. FITB’s SI was 19.25 million shares in April as released by FINRA. Its down 2.67% from 19.77 million shares previously. With 5.50M avg volume, 4 days are for Fifth Third Bancorp (NASDAQ:FITB)’s short sellers to cover FITB’s short positions. The SI to Fifth Third Bancorp’s float is 2.57%. The stock decreased 1.60% or $0.39 during the last trading session, reaching $24.01. About shares traded. Fifth Third Bancorp (NASDAQ:FITB) has risen 18.80% since September 12, 2016 and is uptrending. It has outperformed by 10.32% the S&P500.

Analysts expect Novartis AG (ADR) (NYSE:NVS) to report $1.15 EPS on April, 20.They anticipate $0.02 EPS change or 1.71% from last quarter’s $1.17 EPS. NVS’s profit would be $3.04B giving it 15.85 P/E if the $1.15 EPS is correct. After having $1.12 EPS previously, Novartis AG (ADR)’s analysts see 2.68% EPS growth. The stock decreased 0.55% or $0.4 during the last trading session, reaching $72.93. About 25 shares traded. Novartis AG (ADR) (NYSE:NVS) has declined 9.16% since September 12, 2016 and is downtrending. It has underperformed by 17.64% the S&P500.

Novartis AG is a holding company, which provides healthcare solutions. The company has market cap of $192.98 billion. The Firm is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. It has a 26.07 P/E ratio. The Company’s divisions include Innovative Medicines, Sandoz, Alcon and Corporate activities.

Among 13 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 20 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Tuesday, March 29 by Citigroup. UBS downgraded the stock to “Neutral” rating in Friday, April 1 report. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Neutral” rating by JP Morgan on Tuesday, January 3. Argus Research upgraded Novartis AG (ADR) (NYSE:NVS) on Thursday, November 10 to “Buy” rating. Leerink Swann downgraded the shares of NVS in report on Wednesday, March 23 to “Market Perform” rating. The rating was downgraded by Cowen & Co to “Market Perform” on Wednesday, April 5. The stock has “Underperform” rating by Morgan Stanley on Tuesday, April 12. Societe Generale upgraded Novartis AG (ADR) (NYSE:NVS) on Wednesday, March 8 to “Buy” rating. Chardan Capital Markets maintained it with “Buy” rating and $92 target in Monday, October 10 report. On Tuesday, September 20 the stock rating was initiated by Chardan Capital Markets with “Buy”.

Since November 10, 2016, it had 0 buys, and 10 sales for $4.80 million activity. Borton Chad M sold $496,341 worth of Fifth Third Bancorp (NASDAQ:FITB) on Thursday, November 10. Another trade for 21,708 shares valued at $510,355 was made by Leonard James C. on Thursday, November 10. Another trade for 18,072 shares valued at $430,547 was sold by Forrest Frank R.. 4,000 Fifth Third Bancorp (NASDAQ:FITB) shares with value of $104,840 were sold by Spence Timothy. On Friday, November 18 McHugh Philip sold $764,673 worth of Fifth Third Bancorp (NASDAQ:FITB) or 29,777 shares. CARMICHAEL GREG D sold $924,575 worth of Fifth Third Bancorp (NASDAQ:FITB) on Wednesday, November 16. Tanner Teresa J. had sold 3,220 shares worth $82,701.

Among 28 analysts covering Fifth Third (NASDAQ:FITB), 5 have Buy rating, 3 Sell and 20 Hold. Therefore 18% are positive. Fifth Third had 53 analyst reports since July 22, 2015 according to SRatingsIntel. The company was downgraded on Wednesday, October 21 by Guggenheim. The rating was upgraded by Bernstein to “Mkt Perform” on Wednesday, August 26. The firm has “Neutral” rating given on Wednesday, November 30 by Wedbush. The rating was upgraded by Rafferty to “Buy” on Friday, September 16. The firm has “Buy” rating by Sterne Agee CRT given on Thursday, August 20. The stock has “Mkt Perform” rating by Keefe Bruyette & Woods on Tuesday, October 4. The firm has “Neutral” rating by Sterne Agee CRT given on Wednesday, April 6. The firm earned “Hold” rating on Monday, January 4 by Sandler O’Neill. The rating was downgraded by Jefferies on Friday, October 7 to “Hold”. Jefferies maintained Fifth Third Bancorp (NASDAQ:FITB) on Friday, May 27 with “Buy” rating.